Biotech firm Pharming losses widen
Friday 17 October 2008
Leiden-based biotech firm Pharming announced on Friday a net loss in the third quarter of 2008 of €7.2m, up from €6.4m in the year earlier period.
Turnover in the first nine months of the year dropped to €400,000 compared with €600,000 in the same period in 2007. The cash position improved from €14.1m in 2007 to €33.7m in 2008.
In a statement, Pharming CEO Francis Pinto confirmed the company is pressing ahead with its application for official approval of Rhucin to treat allergic swelling reactions known as angioedema.
© DutchNews.nl
Comments have been closed for this article.
|
Monday: Between 2º and 5º with light snow or sleet. Around zero at night. Similar Tuesday
